You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨康華生物大漲7.7% 截至12月底已累計回購33.4萬股
格隆匯 01-05 10:46
格隆匯1月5日丨康華生物(300841.SZ)大漲7.7%,報244.7元創逾五個月新高,近四個交易日累計漲幅達35%,最新總市值220億元。康華生物公佈,截至2021年12月31日,公司通過股票回購專用證券賬户以集中競價交易方式回購公司股份33.4萬股,佔公司總股本的比例為0.37%,成交總金額為5588.43萬元(不含交易費用)。此外,康華生物12月28日在投資者互動平台表示,信然博創擁有mRNA疫苗技術開發的技術優勢,公司通過與信然博創合作進行基於mRNA技術平台的疫苗開發,充分利用雙方各自擁有的研發、註冊、臨牀、產業化和營銷方面豐富的經驗和專業能力,有利於公司建立mRNA疫苗技術平台,進一步拓展公司研發產品線,有利於公司的長遠發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account